Abdulrahman Manajaa Alotaibi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Abdulrahman Manajaa Alotaibi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adel Abdullah Alshehri
Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
1 shared publication - Ahmed Mohammed Aldhfayan
Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
1 shared publication - Jamal Abdulrahman Almosa
Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
1 shared publication - Mohamed Yacin Sikkandar
Department of Medical Equipment Technology, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia
1 shared publication - Rashed Almousa
Department of Medical Equipment Technology, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia
1 shared publication - Sabarunisha Begum Sheik
Department of Biotechnology, P.S.R. Engineering College, Sivakasi 626140, India
1 shared publication
Latest Publications
- 1 January 2025
- Published by World Scientific Pub Co Pte Ltd in Innovation and Emerging Technologies
- Vol. 12
LSTM-based prediction of cognitive impairment and cerebral perfusion in type 2 diabetes using multimodal data for surgical risk assessment
Cognitive impairment (CI) and cerebral perfusion (CP) abnormalities are common in individuals with type 2 diabetes (T2D), contributing to an increased risk of cognitive decline due to vascular complications that reduce cerebral blood flow (CBF). However, most existing studies have examined these issues in isolation and lack integrated predictive models. This study aimed to develop a long short-term memory (LSTM)-based framework to predict both cognitive decline and CP abnormalities in patients with T2D. Data from 50 patients, including key parameters related to diabetic complications, were analyzed. The random forest (RF) method was used for feature selection, ranking variables by importance. The primary prediction targets were the Mini-Mental State Examination (MMSE) total score for cognitive decline and perfusion vascular (whole brain) for CP. LSTM models effectively captured temporal patterns, and performance was evaluated using k-fold cross-validation with mean absolute error (MAE), mean squared error (MSE), and R-squared ([ ]) as metrics. Results demonstrated strong predictive performance: for cognitive decline, the test MAE was 1.35, MSE 4.01, and [ ] 0.35; for CP, the test MAE was 1.05, MSE 2.20, and [ ] 0.44. Integrating RF with LSTM improved prediction accuracy compared to conventional models such as artificial neural networks (ANNs). Clinically, this framework may support early diagnosis, personalized interventions, and risk stratification in patients with diabetes. In particular, accurate prediction of cognitive and perfusion abnormalities could enhance preoperative assessment and surgical planning in diabetic patients undergoing vascular or neurocognitive-related procedures, thereby reducing perioperative risks and improving patient outcomes.
- 1 January 2025
- Published by World Scientific Pub Co Pte Ltd in Innovation and Emerging Technologies
- Vol. 12
LSTM-based prediction of cognitive impairment and cerebral perfusion in type 2 diabetes using multimodal data for surgical risk assessment
Cognitive impairment (CI) and cerebral perfusion (CP) abnormalities are common in individuals with type 2 diabetes (T2D), contributing to an increased risk of cognitive decline due to vascular complications that reduce cerebral blood flow (CBF). However, most existing studies have examined these issues in isolation and lack integrated predictive models. This study aimed to develop a long short-term memory (LSTM)-based framework to predict both cognitive decline and CP abnormalities in patients with T2D. Data from 50 patients, including key parameters related to diabetic complications, were analyzed. The random forest (RF) method was used for feature selection, ranking variables by importance. The primary prediction targets were the Mini-Mental State Examination (MMSE) total score for cognitive decline and perfusion vascular (whole brain) for CP. LSTM models effectively captured temporal patterns, and performance was evaluated using k-fold cross-validation with mean absolute error (MAE), mean squared error (MSE), and R-squared ([ ]) as metrics. Results demonstrated strong predictive performance: for cognitive decline, the test MAE was 1.35, MSE 4.01, and [ ] 0.35; for CP, the test MAE was 1.05, MSE 2.20, and [ ] 0.44. Integrating RF with LSTM improved prediction accuracy compared to conventional models such as artificial neural networks (ANNs). Clinically, this framework may support early diagnosis, personalized interventions, and risk stratification in patients with diabetes. In particular, accurate prediction of cognitive and perfusion abnormalities could enhance preoperative assessment and surgical planning in diabetic patients undergoing vascular or neurocognitive-related procedures, thereby reducing perioperative risks and improving patient outcomes.